Provided by Tiger Trade Technology Pte. Ltd.

Teladoc Health Inc.

6.39
-0.1000-1.54%
Post-market: 6.400.0146+0.23%19:59 EDT
Volume:3.47M
Turnover:22.26M
Market Cap:1.16B
PE:-6.44
High:6.54
Open:6.50
Low:6.35
Close:6.49
52wk High:9.89
52wk Low:4.40
Shares:181.65M
Float Shares:180.76M
Volume Ratio:0.98
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9925
EPS(LYR):-1.1400
ROE:-12.99%
ROA:-3.22%
PB:0.89
PE(LYR):-5.61

Loading ...

Teladoc Adds Susan Salka to Expanded Board of Directors

TIPRANKS
·
Mar 31

Teladoc appoints former AMN Healthcare CEO Susan Salka to board

Reuters
·
Mar 31

Teladoc Health Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Mar 26

Teladoc price target lowered to $7 from $8.50 at Barclays

TIPRANKS
·
Mar 26

Teladoc (TDOC) Gets a Hold from Barclays

TIPRANKS
·
Mar 26

Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC)

TIPRANKS
·
Mar 17

Teladoc Health Is Maintained at Neutral by JP Morgan

Dow Jones
·
Mar 14

J.P. Morgan Releases a Hold Rating on Teladoc (TDOC)

TIPRANKS
·
Mar 13

Teladoc Health Shares Rise After Deutsche Bank Upgrade

MT Newswires Live
·
Mar 11

Teladoc Health Stock Pops - Here's Why

Benzinga_recent_news
·
Mar 10

Top Premarket Gainers

MT Newswires Live
·
Mar 10

Deutsche Bank Upgrades Teladoc Health to Buy From Hold

MT Newswires Live
·
Mar 10

Teladoc call volume above normal and directionally bullish

TIPRANKS
·
Mar 10

Teladoc Health Grants New Chief Growth Officer Equity Inducement Award

Reuters
·
Mar 05

Teladoc BetterHelp President Fernando M. Rodrigues Disposes of Common Shares

Reuters
·
Mar 04

Teladoc Health CEO Chuck Divita to Speak at Barclays Global Healthcare Conference

Reuters
·
Mar 04

Mental health startup Grow Therapy valued at $3 billion in latest fundraise

Reuters
·
Mar 04

Teladoc Health Is Maintained at Neutral by Citigroup

Dow Jones
·
Mar 04

Oppenheimer Adjusts Price Target on Teladoc Health to $7 From $12, Maintains Outperform Rating

MT Newswires Live
·
Mar 03

Teladoc Health : Oppenheimer Cuts Target Price to $7 From $12

THOMSON REUTERS
·
Mar 03